featured
Mortality Risk With Extended-Duration Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mortality in Patients Treated With Extended Duration Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Pairwise and Bayesian Network Meta-Analysis of Randomised Trials
Lancet 2015 Mar 13;[EPub Ahead of Print], T Palmerini, U Benedetto, L Bacchi-Reggiani, DD Riva, G Biondi-Zoccai, F Feres, A Abizaid, MK Hong, BK Kim, Y Jang, HS Kim, KW Park, P Genereux, DL Bhatt, C Orlandi, S De Servi, M Petrou, C Rapezzi, GW StoneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.